{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:02:39Z","timestamp":1784599359425,"version":"3.55.0"},"reference-count":44,"publisher":"ARAN Ediciones","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.hipert.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T09:11:19Z","timestamp":1690535479000},"page":"5-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mortality and cardiovascular risk in vasculitis ANCA. Importance of hypertension and renal function. Experience from southern Spain"],"prefix":"10.20960","volume":"41","author":[{"given":"M.A.","family":"Martin-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rodr\u00edguez Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Espinosa Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lopez Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Sabio S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Martin Armada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Martin Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Callejas Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Castilla Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Anglada Pintado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Barnosi Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Martinez Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Castilla Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"De Ram\u00f3n Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.hipert.2023.06.001_bib0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","article-title":"French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)","volume":"15","author":"Terrier","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.hipert.2023.06.001_bib0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-associated vasculitis: core curriculum 2020","volume":"75","author":"Geetha","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hipert.2023.06.001_bib0235","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jep.12709","article-title":"Management of cardiovascular risk factors in patients with ANCA-associated vasculitis","volume":"23","author":"Bramlage","year":"2017","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.hipert.2023.06.001_bib0240","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2011.01.004","article-title":"Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment","volume":"10","author":"Solt\u00e9sz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.hipert.2023.06.001_bib0245","first-page":"126","article-title":"Early development of new cardiovascular risk factors in the systemic vasculitides","volume":"38","author":"Monti","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.hipert.2023.06.001_bib0250","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.ATV.0000174800.78362.ec","article-title":"Atherosclerosis in patients with autoimmune disorders","volume":"25","author":"Frosteg\u00e5rd","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hipert.2023.06.001_bib0255","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/art.27551","article-title":"Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus","volume":"62","author":"Scalzi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.hipert.2023.06.001_bib0260","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hipert.2023.06.001_bib0265","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.semarthrit.2017.07.004","article-title":"The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: a study of 504 cases in a single Chinese center","volume":"47","author":"Bai","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.hipert.2023.06.001_bib0270","unstructured":"IMIM cat. Calculadora de risk cardiovascular REGICOR [Internet]; 2012. Available from: https:\/\/www.imim.cat\/ofertadeserveis\/software-public\/regicor\/?1 [cited 20.6.20]."},{"key":"10.1016\/j.hipert.2023.06.001_bib0275","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hipert.2023.06.001_bib0280","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018 practice guidelines for the management of arterial hypertension of the European society of cardiology and the European society of hypertension ESC\/ESH task force for the management of arterial hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2023.06.001_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.hipert.2023.06.001_bib0290","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hipert.2023.06.001_bib0295","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in Diabetes 2018","volume":"41","author":"Care","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hipert.2023.06.001_bib0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/ard.2005.051078","article-title":"Development of comprehensive disease assessment in systemic vasculitis","volume":"84","author":"Flossmann","year":"2008","journal-title":"Postgrad Med J"},{"issue":"Part B","key":"10.1016\/j.hipert.2023.06.001_bib0305","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3S","key":"10.1016\/j.hipert.2023.06.001_bib0310","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Hypertension Work Group. KDIGO Clinica Practice Guideline for the mangement of blood pressure in chronic kidney disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney International."},{"key":"10.1016\/j.hipert.2023.06.001_bib0315","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO Clinica Practice Guideline for the diabetes mangement in chronic kidney disease","volume":"99","author":"Caramori","year":"2020","journal-title":"Kidney International"},{"key":"10.1016\/j.hipert.2023.06.001_bib0320","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) lipid work group KDIGO clinical practice guideline for lipid management in chronic kidney disease","volume":"3","author":"Tonelli","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.hipert.2023.06.001_bib0325","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/rheumatology\/kez229","article-title":"Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitis","volume":"58","author":"Houben","year":"2019","journal-title":"Rheumatology (UK)"},{"key":"10.1016\/j.hipert.2023.06.001_bib0330","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","volume":"59","author":"Wallace","year":"2020","journal-title":"Rheumatology (UK)"},{"key":"10.1016\/j.hipert.2023.06.001_bib0335","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.mayocp.2018.02.010","article-title":"Risk of cardiovascular disease and venous thromboembolism among patients with incident ANCA-associated vasculitis: a 20-year population-based cohort study","volume":"93","author":"Berti","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hipert.2023.06.001_bib0340","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/bph.14604","article-title":"Mechanisms of hypertension in autoimmune rheumatic diseases","volume":"176","author":"Taylor","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.hipert.2023.06.001_bib0345","doi-asserted-by":"crossref","first-page":"102708","DOI":"10.1016\/j.autrev.2020.102708","article-title":"Comorbidities and health-related quality of life in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"20","author":"Mercuzot","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.hipert.2023.06.001_bib0350","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.recesp.2010.11.005","article-title":"Factores de riesgo cardiovascular en Espa\u00f1a en la primera d\u00e9cada del siglo XXI: an\u00e1lisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS","volume":"64","author":"Grau","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hipert.2023.06.001_bib0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00125-011-2336-9","article-title":"Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es study","volume":"55","author":"Soriguer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.hipert.2023.06.001_bib0360","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.ki.5002142","article-title":"Hypertension: the kidney is the culprit even in the absence of kidney disease","volume":"71","author":"Ritz","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.hipert.2023.06.001_bib0365","first-page":"429","article-title":"The role of the kidney in essential hypertension","volume":"35","author":"Saruta","year":"1993","journal-title":"Jpn J Nephrol"},{"key":"10.1016\/j.hipert.2023.06.001_bib0370","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.114.014310","article-title":"Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort the PESA (Progression of Early Subclinical Atherosclerosis) study","volume":"131","author":"Fern\u00e1ndez-Friera","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2023.06.001_bib0375","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/acr.20433","article-title":"A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis","volume":"63","author":"Suppiah","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.hipert.2023.06.001_bib0380","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3899\/jrheum.130882","article-title":"Factors associated with major cardiovascular events in patients with systemic necrotizing vasculitides: results of a longterm followup study","volume":"41","author":"Terrier","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.hipert.2023.06.001_bib0385","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/kex338","article-title":"Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies","volume":"57","author":"Houben","year":"2018","journal-title":"Rheumatology (UK)"},{"key":"10.1016\/j.hipert.2023.06.001_bib0390","series-title":"ANCA-associated vasculitis: data from the Toronto CanVasc cohort","first-page":"10","author":"Houben","year":"2020"},{"key":"10.1016\/j.hipert.2023.06.001_bib0395","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2023.06.001_bib0400","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1001\/jama.291.21.2616","article-title":"The global burden of chronic diseases: overcoming impediments to prevention and control","volume":"291","author":"Yach","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2023.06.001_bib0405","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.reuma.2017.11.003","article-title":"Clinical significance of neutrophil\/lymphocyte ratio in patients with granulomatosis with polyangiitis","volume":"15","author":"Abaza","year":"2019","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.hipert.2023.06.001_bib0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-015-0047-z","article-title":"Thrombosis in vasculitis: from pathogenesis to treatment","volume":"13","author":"Emmi","year":"2015","journal-title":"Thromb J"},{"key":"10.1016\/j.hipert.2023.06.001_bib0415","doi-asserted-by":"crossref","first-page":"iii79","DOI":"10.1093\/rheumatology\/kez617","article-title":"Comorbidities in ANCA-associated vasculitis","volume":"59","author":"Kronbichler","year":"2020","journal-title":"Rheumatology (UK)"},{"key":"10.1016\/j.hipert.2023.06.001_bib0420","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hipert.2023.06.001_bib0425","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2023.06.001_bib0430","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hipert.2023.06.001_bib0435","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/1744666X.2018.1538789","article-title":"Mortality in systemic lupus erythematosus: causes, predictors and interventions","volume":"14","author":"Ocampo-Piraquive","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.hipert.2023.06.001_bib0440","doi-asserted-by":"crossref","first-page":"e23022","DOI":"10.1002\/jcla.23022","article-title":"Multivariable index for assessing the activity and predicting all-cause mortality in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"34","author":"Kim","year":"2020","journal-title":"J Clin Lab Anal"}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183723000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183723000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:37Z","timestamp":1784596537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183723000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1889183723000363"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2023.06.001","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality and cardiovascular risk in vasculitis ANCA. Importance of hypertension and renal function. Experience from southern Spain","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SEH-LELHA. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}